Literature DB >> 26472734

Sugar-coated signaling in follicular lymphoma.

Matthew P Strout1.   

Abstract

In this issue of Blood, complementary studies by Amin et al and Linley et al demonstrate that sugar moieties linked to surface immunoglobulin (sIg) of follicular lymphoma (FL) cells directly interact with endogenous lectins within the lymphoma niche and lead to activation of downstream B-cell receptor (BCR) signaling pathways. In addition to providing further insight into the role of the microenvironment in lymphomagenesis, these findings expose a unique molecular interaction that may represent a viable target for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26472734     DOI: 10.1182/blood-2015-08-665141

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  3 in total

1.  Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing.

Authors:  A Zamò; J Pischimarov; M Schlesner; P Rosenstiel; R Bomben; H Horn; T Grieb; T Nedeva; C López; A Haake; J Richter; L Trümper; C Lawerenz; W Klapper; P Möller; M Hummel; D Lenze; M Szczepanowski; L Flossbach; M Schreder; V Gattei; G Ott; R Siebert; A Rosenwald; E Leich
Journal:  Leukemia       Date:  2017-08-21       Impact factor: 11.528

2.  IGHV sequencing reveals acquired N-glycosylation sites as a clonal and stable event during follicular lymphoma evolution.

Authors:  Mariette Odabashian; Emanuela Carlotti; Shamzah Araf; Jessica Okosun; Filomena Spada; John G Gribben; Francesco Forconi; Freda K Stevenson; Mariarita Calaminici; Sergey Krysov
Journal:  Blood       Date:  2020-03-12       Impact factor: 22.113

Review 3.  Successful PD-1 inhibitor treatment in a patient with refractory transformed follicular lymphoma who failed to respond to CAR-T cell therapy: a case report and literature review.

Authors:  Weicheng Zheng; Qingfeng Xue; Xueping Sha; Yao Wang; Yuan Wang; Juan Liu; Yaping Zhang; Wenyu Shi
Journal:  Cancer Biol Ther       Date:  2021-09-27       Impact factor: 4.875

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.